<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>To assess adherence to <z:chebi fb="0" ids="49200">proton pump inhibitor</z:chebi> (<z:chebi fb="4" ids="53266">PPI</z:chebi>) treatment and associated variables in patients with <z:hpo ids='HP_0002020'>gastroesophageal reflux disease</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">GERD</z:e>) </plain></SENT>
<SENT sid="1" pm="."><plain>Cross-sectional and prospective comprising 240 consecutive adult patients, diagnosed with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">GERD</z:e> for whom continuous use of standard or double dose of <z:chebi fb="14" ids="7772">omeprazole</z:chebi> had been prescribed </plain></SENT>
<SENT sid="2" pm="."><plain>Patients were ranked as ne-<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">GERD</z:e> (162: 67.5%) or e-<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">GERD</z:e> classified according to the Los Angeles classification as A (48:20.0%), B (21:8.6%), C (1:0.5%), D (1:0.5%), and <z:hpo ids='HP_0100580'>Barrett's esophagus</z:hpo> (7:2.9%) </plain></SENT>
<SENT sid="3" pm="."><plain>The Morisky questionnaire was applied to assess adherence to therapy and a <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">GERD</z:e> questionnaire to assess symptoms and their impact </plain></SENT>
<SENT sid="4" pm="."><plain>Adherence was correlated with demographics, cotherapies, comorbidities, treatment duration, symptoms scores, endoscopic findings, and patient awareness of their disease </plain></SENT>
<SENT sid="5" pm="."><plain>126 patients (52.5%) exhibited high level of adherence and 114 (47.5%) low level </plain></SENT>
<SENT sid="6" pm="."><plain>Youngers (P= 0.002) or married (O.R </plain></SENT>
<SENT sid="7" pm="."><plain>2.41, P= 0.03 vs. widowers) patients had lower levels of adherence; symptomatic patients exhibited lower adherence (P= 0.02) </plain></SENT>
<SENT sid="8" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> other variables studied had no influence on adherence </plain></SENT>
<SENT sid="9" pm="."><plain>Patients with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">GERD</z:e> attending a tertiary referral hospital in SÃ£o Paulo exhibited a high rate of low adherence to the prescribed <z:chebi fb="4" ids="53266">PPI</z:chebi> therapy that may play a role in the therapy failure </plain></SENT>
<SENT sid="10" pm="."><plain>Age &lt;60 years, marital status and being symptomatic were risk factors for low adherence </plain></SENT>
</text></document>